{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/18/3276558/0/en/Press-Release-ESCMID-Sanofi-s-Nuvaxovid-COVID-19-vaccine-showed-better-tolerability-than-mNEXSPIKE-in-head-to-head-study.html", "message": "News view counter 670571 successfully enlarged"}